International Stem Cell's market cap is currently ―. The company's EPS TTM is $-0.045; its P/E ratio is -2.20; International Stem Cell is scheduled to report earnings on April 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 1.97M	$ 1.84M	$ 2.09M	$ 2.43M	$ 1.70M
Gross Profit	$ 1.97M	$ 1.13M	$ 1.26M	$ 1.29M	$ 1.01M
EBIT	$ -97.00K	$ 294.00K	$ 2.00K	$ 90.00K	$ -308.00K
EBITDA	$ -50.00K	$ 342.00K	$ -29.00K	$ 25.00K	$ -253.00K
Net Income Common Stockholders	$ -131.00K	$ 259.00K	$ -34.00K	$ 23.00K	$ -343.00K
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 1.43M	$ 1.38M	$ 943.00K	$ 742.00K	$ 666.00K
Total Assets	$ 5.64M	$ 5.79M	$ 5.34M	$ 5.13M	$ 5.04M
Total Debt	$ 4.21M	$ 4.23M	$ 4.25M	$ 4.28M	$ 4.29M
Net Debt	$ 2.77M	$ 2.85M	$ 3.31M	$ 3.53M	$ 3.63M
Total Liabilities	$ 5.20M	$ 9.63M	$ 5.49M	$ 5.36M	$ 9.69M
Stockholders Equity	$ -3.86M	$ -3.85M	$ -4.45M	$ -4.52M	$ -4.65M
Cash Flow	-
Free Cash Flow	$ 48.00K	$ 439.00K	$ 201.00K	$ 76.00K	$ 80.00K
Operating Cash Flow	$ 62.00K	$ 490.00K	$ 216.00K	$ 79.00K	$ 84.00K
Investing Cash Flow	$ -14.00K	$ -51.00K	$ -15.00K	$ -3.00K	$ -4.00K
Financing Cash Flow	-	-	-	-	$ 0.00

Currency in USD

International Stem Cell Earnings and Revenue History

Income Statement >

International Stem Cell Debt to Assets

Balance Sheet >

International Stem Cell Cash Flow

Cash Flow >

International Stem Cell Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing